3Baker R. Kidney dysfunction: a safety update on adefovir (pre ) [ J ]. BETA, 1998:9-10.
4Fisher E J, Chaloner K, Cohn D L, et al. The safety and ef- ficacy of adefovir dipivoxil in patients with advanced IqIV disease : a randomized, placebo-controlled trial [ J ]. AIDS, 2001,15(13) :1695-1700.
5Benhamou Y, Bochet M, Thibault V, et al. Safety and effi- cacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pi- lot study[J]. Lancet, 2001,358(9283) :718-723.
6Fontana R J. Side effects of long-term oral antiviral therapy for hepatitis B [ J ]. Hepatology, 2009,49 (5 suppl) : 185-195.
8Izzedine H, Kheder Elfekih R, Housset P, et al. Adefovir dipivoxil-induced acute tubular necrosis and Fanconi syn- drome in a renal transplant patient [ J ]. AIDS, 2009,23 (4) : 544-545.
9Wong T, Girgis C M, Ngu M C, et al. Hypophosphatemic os- teomalacia after low-dose adefovir dipivoxil therapy for hepatitis B[J].J Clin Endocrinol Metab, 2010,95(2):479-480.
10Kahn J, Lagakos S, Wulfsohn M, et al dipivoxil with antiretroviral therapy: JAMA, 1999,282(24) :2305-2312.
